ABG Management Ltd, 10% Owner at Sorrento Therapeutics, Inc. (SRNE), sold 595,136 shares at $4.92 ($3.0M) on 2018-09-13, disclosed to the SEC on 2018-09-14.
Open-market sale of $3.0M SRNE by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.06 | 189,754 | $960K | 32.2% |
| 2 | $5.06 | 189,754 | $960K | 32.2% |
| 3 | $4.92 | 78,677 | $387K | 13.0% |
| 4 | $4.92 | 78,677 | $387K | 13.0% |
| 5 | $5.01 | 29,137 | $146K | 4.9% |
| 6 | $5.01 | 29,137 |
| $146K |
| 4.9% |
| Total | $5.02 avg | 595,136 | $3.0M | 100% |